Research chemicals: Difference between revisions

>Josikins
>Josikins
m Text replacement - "stimulants" to "stimulants"
Line 9: Line 9:
The safety profile of research chemicals is generally unknown due to a lack of medical studies. There is little to no information on the toxicity, negative health risks, long-term side effects, or lethal dosage of these chemicals, which make their use more risky than the use of more common, well-studied substances. It is for these reasons that taking these chemicals for extended periods of time, binging on them, and taking excessive doses is strongly discouraged.
The safety profile of research chemicals is generally unknown due to a lack of medical studies. There is little to no information on the toxicity, negative health risks, long-term side effects, or lethal dosage of these chemicals, which make their use more risky than the use of more common, well-studied substances. It is for these reasons that taking these chemicals for extended periods of time, binging on them, and taking excessive doses is strongly discouraged.


In terms of known risk factors, common issues for research chemicals include the the mislabeling, misidentification, and misrepresentation of products; the adulteration of other compounds; and issues of purity.<ref name="erowid">Experimental & Research Chemicals (Synthetic Drugs, Novel Psychoactive Substances, New Psychoactive Substances, NPS, Replacement Psychoactives) (Erowid) | https://www.erowid.org/psychoactives/research_chems/</ref> Combining research chemicals presents a risk due to the lack of research and understanding of the drugs' pharmacology. For example, if a research chemical has [[MAOI]] effects (like 2C-T-7), this could make it dangerous to combine it with other [[MAOI]]s, [[stimulants]] and certain substances which release [[serotonin]] or [[dopamine]]. It is recommended to avoid blends or branded products if the active psychoactive compounds are not listed on the labelling.<ref name="tripsit">Research Chemicals (Tripsit) | https://wiki.tripsit.me/wiki/Research_Chemicals</ref>
In terms of known risk factors, common issues for research chemicals include the the mislabeling, misidentification, and misrepresentation of products; the adulteration of other compounds; and issues of purity.<ref name="erowid">Experimental & Research Chemicals (Synthetic Drugs, Novel Psychoactive Substances, New Psychoactive Substances, NPS, Replacement Psychoactives) (Erowid) | https://www.erowid.org/psychoactives/research_chems/</ref> Combining research chemicals presents a risk due to the lack of research and understanding of the drugs' pharmacology. For example, if a research chemical has [[MAOI]] effects (like 2C-T-7), this could make it dangerous to combine it with other [[MAOI]]s, [[stimulant]]s and certain substances which release [[serotonin]] or [[dopamine]]. It is recommended to avoid blends or branded products if the active psychoactive compounds are not listed on the labelling.<ref name="tripsit">Research Chemicals (Tripsit) | https://wiki.tripsit.me/wiki/Research_Chemicals</ref>


Several fatal overdoses have occurred due to [[Bromo-DragonFLY]] accidentally being mislabelled by online vendors as both [[2C-B-Fly]]<ref name="2cbfly">Information on Reported Deaths Related to 2C-B-Fly Misidentified Substance is Most Likely Bromo-dragonfly by the Erowid Crew v1.6 - Nov 9, 2009 | https://www.erowid.org/chemicals/2cb_fly/2cb_fly_death1.shtml</ref> and [[2C-E]].<ref name="2ce">Bromo-Dragonfly Fatalities / Deaths by Erowid | https://www.erowid.org/chemicals/bromo_dragonfly/bromo_dragonfly_death.shtml</ref><ref name="2ce2">Second Victim Dies After Taking Designer Drug In Konawa | http://www.newson6.com/story/14641463/second-victim-dies-after-taking-designer-drug-in-konawa</ref> The former is active in the 200-800ug range and is significantly more potent than 2C-E. Situations like this can be avoided by simply dosing a minuscule amount of a drug (roughly 0.5 milligrams) and waiting for several hours. It is recommended to do this for all new batches of drugs that you do not completely trust.
Several fatal overdoses have occurred due to [[Bromo-DragonFLY]] accidentally being mislabelled by online vendors as both [[2C-B-Fly]]<ref name="2cbfly">Information on Reported Deaths Related to 2C-B-Fly Misidentified Substance is Most Likely Bromo-dragonfly by the Erowid Crew v1.6 - Nov 9, 2009 | https://www.erowid.org/chemicals/2cb_fly/2cb_fly_death1.shtml</ref> and [[2C-E]].<ref name="2ce">Bromo-Dragonfly Fatalities / Deaths by Erowid | https://www.erowid.org/chemicals/bromo_dragonfly/bromo_dragonfly_death.shtml</ref><ref name="2ce2">Second Victim Dies After Taking Designer Drug In Konawa | http://www.newson6.com/story/14641463/second-victim-dies-after-taking-designer-drug-in-konawa</ref> The former is active in the 200-800ug range and is significantly more potent than 2C-E. Situations like this can be avoided by simply dosing a minuscule amount of a drug (roughly 0.5 milligrams) and waiting for several hours. It is recommended to do this for all new batches of drugs that you do not completely trust.
Line 18: Line 18:


====Psychedelics====
====Psychedelics====
*'''[[AMT]]''' - Deaths from AMT are rare<ref name="amt">AMT (Alphamethyltryptamine, IT-290) Fatalities / Deaths by Erowid | https://www.erowid.org/chemicals/amt/amt_death.shtml</ref><ref name="amt2">Boland DM, Andollo W, Hime GW, Hearn WL. “Fatality due to acute alpha-methyltryptamine intoxication”. J Anal Toxicol. 2005 Jul-Aug;29(5):394-7. | https://www.erowid.org/references/refs_view.php?ID=6603</ref> but, as a powerful [[monoamine]] [[reuptake inhibitor]] (MRI), injury could occur when excessive doses are taken or when it is taken with drugs such as [[MAOIs]], [[RIMA]]s, [[stimulants]] and any substance which act as a [[releasing agent]] or [[reuptake inhibitor]] of [[neurotransmitters]] such as [[serotonin]] and [[dopamine]].<ref>Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity | http://bja.oxfordjournals.org/content/95/4/434</ref>
*'''[[AMT]]''' - Deaths from AMT are rare<ref name="amt">AMT (Alphamethyltryptamine, IT-290) Fatalities / Deaths by Erowid | https://www.erowid.org/chemicals/amt/amt_death.shtml</ref><ref name="amt2">Boland DM, Andollo W, Hime GW, Hearn WL. “Fatality due to acute alpha-methyltryptamine intoxication”. J Anal Toxicol. 2005 Jul-Aug;29(5):394-7. | https://www.erowid.org/references/refs_view.php?ID=6603</ref> but, as a powerful [[monoamine]] [[reuptake inhibitor]] (MRI), injury could occur when excessive doses are taken or when it is taken with drugs such as [[MAOIs]], [[RIMA]]s, [[stimulant]]s and any substance which act as a [[releasing agent]] or [[reuptake inhibitor]] of [[neurotransmitters]] such as [[serotonin]] and [[dopamine]].<ref>Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity | http://bja.oxfordjournals.org/content/95/4/434</ref>
*'''[[DOC]]''' - There is one reported death from DOC, however, the toxicology report hasn't been released nor has the presence of DOC been confirmed.<ref>DOC (2,5-Dimethoxy-ChloroAmphetamine) Fatalities / Deaths by Erowid | https://www.erowid.org/chemicals/doc/doc_death.shtml</ref>
*'''[[DOC]]''' - There is one reported death from DOC, however, the toxicology report hasn't been released nor has the presence of DOC been confirmed.<ref>DOC (2,5-Dimethoxy-ChloroAmphetamine) Fatalities / Deaths by Erowid | https://www.erowid.org/chemicals/doc/doc_death.shtml</ref>
*'''[[2C-T-7]]''' - There have been at least three reported deaths related to 2C-T-7 use at insufflated (nasal) doses of 30 mg or more<ref name="one">A Reported 2C-T-7 Death by Erowid July 2003 | https://www.erowid.org/chemicals/2ct7/2ct7_death1.shtml</ref><ref name="two">Second Reported 2C-T-7 Death by Erowid Apr 2, 2001 | https://www.erowid.org/chemicals/2ct7/2ct7_death2.shtml</ref> or combined with stimulants such as [[MDMA]].<ref name="three">Third Confirmed 2C-T-7 Death by Erowid Apr 10, 2001 | https://www.erowid.org/chemicals/2ct7/2ct7_death3.shtml</ref> It is not recommended to [[insufflate]] (snort) this drug or combine it with [[MAOI]]s, [[stimulants]] and certain substances which releases [[serotonin]] or [[dopamine]] because 2C-T-7 may possibly have [[MAOI]] effects.<ref>Sulfur-Substituted α-Alkyl Phenethylamines as Selective and Reversible MAO-A Inhibitors:  Biological Activities, CoMFA Analysis, and Active Site Modeling | http://pubs.acs.org/doi/abs/10.1021/jm0493109</ref>
*'''[[2C-T-7]]''' - There have been at least three reported deaths related to 2C-T-7 use at insufflated (nasal) doses of 30 mg or more<ref name="one">A Reported 2C-T-7 Death by Erowid July 2003 | https://www.erowid.org/chemicals/2ct7/2ct7_death1.shtml</ref><ref name="two">Second Reported 2C-T-7 Death by Erowid Apr 2, 2001 | https://www.erowid.org/chemicals/2ct7/2ct7_death2.shtml</ref> or combined with stimulants such as [[MDMA]].<ref name="three">Third Confirmed 2C-T-7 Death by Erowid Apr 10, 2001 | https://www.erowid.org/chemicals/2ct7/2ct7_death3.shtml</ref> It is not recommended to [[insufflate]] (snort) this drug or combine it with [[MAOI]]s, [[stimulant]]s and certain substances which releases [[serotonin]] or [[dopamine]] because 2C-T-7 may possibly have [[MAOI]] effects.<ref>Sulfur-Substituted α-Alkyl Phenethylamines as Selective and Reversible MAO-A Inhibitors:  Biological Activities, CoMFA Analysis, and Active Site Modeling | http://pubs.acs.org/doi/abs/10.1021/jm0493109</ref>
*'''[[25I-NBOMe]]'''<ref name="one">25I-NBOMe (2C-I-NBOMe) Fatalities / Deaths by Erowid | https://www.erowid.org/chemicals/2ci_nbome/2ci_nbome_death.shtml</ref>
*'''[[25I-NBOMe]]'''<ref name="one">25I-NBOMe (2C-I-NBOMe) Fatalities / Deaths by Erowid | https://www.erowid.org/chemicals/2ci_nbome/2ci_nbome_death.shtml</ref>
*'''[[25B-NBOMe]]'''<ref name="three">Other or Unknown NBOMe Compound Fatalities / Deaths by Erowid | https://www.erowid.org/chemicals/nbome/nbome_death.shtml</ref>
*'''[[25B-NBOMe]]'''<ref name="three">Other or Unknown NBOMe Compound Fatalities / Deaths by Erowid | https://www.erowid.org/chemicals/nbome/nbome_death.shtml</ref>